Article Information
PubMed
Print ISSN
Online ISSN
History
- Received February 18, 2010
- Accepted April 16, 2010
- Published online June 17, 2010.
Article Versions
- Earlier version (April 19, 2010 - 07:41).
- You are viewing the most recent version of this article.
Copyright & Usage
Copyright © 2010 by The American Society for Pharmacology and Experimental Therapeutics
Author Information
- Tadashi Ishibashi,
- Tomoko Horisawa,
- Kumiko Tokuda,
- Takeo Ishiyama,
- Masaaki Ogasa,
- Rie Tagashira,
- Kenji Matsumoto,
- Hiroyuki Nishikawa,
- Yoko Ueda,
- Satoko Toma,
- Hitomi Oki,
- Norihiko Tanno,
- Ikutaro Saji,
- Akira Ito1,
- Yukihiro Ohno2 and
- Mitsutaka Nakamura3
- Address correspondence to:
Dr. Takeo Ishiyama, Dainippon Sumitomo Pharma Co., Ltd., 33-94 Enoki-cho, Suita, Osaka 564-0053, Japan. E-mail: takeo-ishiyama{at}ds-pharma.co.jp
Portions of these data were previously presented: Ishibashi T, Horisawa T, Yabuuchi K, Tagashira R, and Ohno Y (2002) Receptor binding characteristics of SM-13496, a novel atypical antipsychotic agent. Annual Meeting of the Society for Neuroscience; 2002 Nov 3–6; Orlando FL. Society for Neuroscience, Washington, DC and also cited in a review article (Meyer et al., 2009).
Tad.I. and T.H. contributed equally to this work.